F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 36 SEK -2.44%
Market Cap: 490.3m SEK

Fluoguide AS
Investor Relations

FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 27, 2025
Q3 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls

Management

Mr. Morten Albrechtsen B.B.A., BBA, M.D.
Chief Executive Officer
No Bio Available
Mr. Ole Larsen Cand. merc., M.Sc.
Chief Financial Officer
No Bio Available
Prof. Andreas Kjaer M.D., M.Sc., Ph.D.
CSO, Head of Scientific Advisory Board & Director
No Bio Available
Dr. Grethe Nørskov Rasmussen M.Sc., Ph.D.
Chief Development Officer
No Bio Available
Ms. Dorthe Gronnegaard Mejer
Vice President of Clinical Development
No Bio Available

Contacts

Address
COPENHAGEN
Ole Maaloees Vej 3, Copenhagen N
Contacts
+4531226660.0
fluoguide.com